title: Commentary on Halpern et al. (2011): strengthening the case against functionally significant serotonergic neurotoxicity in human MDMA (ecstasy) users.
authors.affiliation: Department of Psychology, Bond University, Gold Coast, QLD 4229, Australia. mlyvers@bond.edu.au
authors.forename: Michael
authors.initials: M
authors.lastname: Lyvers
mesh_terms: D005277:Fenfluramine / Q000009:adverse effects*; D006213:Hallucinogens / Q000009:adverse effects; D006801:Humans; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D018490:Serotonin Agents / Q000009:adverse effects*; D055815:Young Adult
chemical_list: D006213:Hallucinogens; D018490:Serotonin Agents; D005277:Fenfluramine; D018817:N-Methyl-3,4-methylenedioxyamphetamine